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Background: Physical Therapy strength training programs utilizing mild to moderate intensity 
are commonly prescribed to address many of the deficits found in multiple sclerosis, but studies 
examining the effectiveness of higher intensity strength training in gait and balance have not 
been performed. Maximal strength training (MST), which involves lifting nearly maximal 
weights (85-95% of an individual’s one repetition maximum [1RM]) with low repetitions, has 
been shown to improve functional abilities in both healthy and non-MS impaired populations. 
The higher intensity training used in MST may result in greater activation of the CNS, providing 
a greater stimulus to improvement than lower intensity training. However, due to concerns 
regarding fatigue, clinicians have avoided using maximal loads for resistance training. To date 
there are no studies that have examined the effects of MST on functional measures in PwMS.  
Purpose: The purpose of this study was to examine the effects of MST on gait and balance in 
PwMS and assess whether MST could be tolerated by this population. We hypothesized that 
MST would result in improved gait and balance measurements in MS patients, and offer 
clinicians another tool with which to improve function in this population. 
Subjects: Subjects with a definitive diagnosis of MS were recruited from a MS specialty 
practice. Inclusionary criteria required the ability to ambulate for 6 minutes, with or without an 
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assistive device. Exclusionary criteria included any type of orthopedic or cardiopulmonary 
condition restricting the ability to walk for 6 minutes, and any exacerbations, either immediately 
prior (2 weeks or less) or during the study. 
Methodology: A pretest/posttest design was used. Baseline measures included subjects’ Berg 
Balance Scale (BBS), 6-minute walk test (6MWT), followed by their 1RM lift for each leg using 
a leg-press machine. Fatigue Severity Scale (FSS) and the MSIS-29 were also collected during 
the initial session. Subjects completed an 8 week protocol consisting of 2 sessions per week, 
performing 4 sets of 4 repetitions using the leg-press for each leg at 85-95% of their 1RM. 
Increases in weight  per session were determined by subject capability and preference as well as 
the ability to complete 4 sets of 4 repetitions of the given weight. Fatigue was measured each 
session using the Visual Analog Fatigue Scale (VAFS) and weekly with the FSS. 
Results: 7 subjects (5 female, 2 male, EDSS 3.57) completed the 8 week MST protocol. There 
were significant changes found in all objective measures from pre to post testing. (1RM, BBS, 
and 6MWT).  Right leg 1RM increased significantly by 82.86 pounds (F(1,6) = 20.26, p = .004), 
and left leg 1RM increased significantly by 72.14 pounds (F(1,6) = 63.03, p < .001). The BBS 
increased significantly by 5.28 points (F(1,6) = 15.56, p = .008).  The 6MWT increased 
significantly by 150.69 feet (F(1,6) = 6.35, p = .045). Subjective perceptions of fatigue while 
walking were not significantly different for the two walking conditions. 
Conclusion: All subjects who completed the study did so without any adverse effects. 
Significant improvements were seen in all objective measures (1RM, BBS, and 6MWT) 
following the MST protocol. This suggests that MST may be a safe and effective measure to 
improve gait and endurance in PwMS.  
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Multiple Sclerosis is a variable and degenerative neurological disease that commonly 
causes impaired gait and balance, fatigue, decreased strength, spasticity, range of motion and 
coordination (Induruwa, Constantinescu, & Gran, 2012; LaRocca, 2011; Ng, Miller, Gelinas, & 
Kent-Braun, 2004). The etiology of MS is the demyelination of axons and formation of 
inflammatory plaque in the central nervous system (CNS) (Frohman, Racke, & Raine, 2006). 
The severity of the disease varies tremendously between persons, as well as where the 
demyelination occurs in the CNS (Frohman et al., 2006), however some symptoms are prominent 
and generally applicable to PwMS. MS-related fatigue is a prominent symptom of MS that can 
lead to gait impairments and a decrease in time dedicated to exercise, thus posing a unique 
challenge to both the patient and physical therapist (Karpatkin et al, 2013). Most progressive 
resistive exercise (PRE) interventions, which generally require three sets of at least 8-12 
repetitions, may be too fatiguing for MS patients to complete. As a result, PwMS may not be 
able to build significant strength and counteract the neural interruptions caused by the disease 
that limit their functional activities. Consequently, there is difficulty finding consistently 
effective interventions to address the functional limitations due to the heterogeneity of the 
disease (Karpatkin, 2005; Lucchinetti et al., 2000).   
Strength training programs utilizing mild to moderate intensity are commonly prescribed 
to address many of the deficits found in MS. Studies applying mild to moderate intensity 
strengthening programs to PwMS provided inconsistent results regarding the exercise programs’ 
effects on their gait and balance (DeBolt & McCubbin, 2004; de Souza-Teixeira et al., 2009). 
Maximal strength training (MST), which involves lifting nearly maximal weights (85-95% of 
one repetition maximum [1RM]) with low repetitions, has been shown to improve functional 
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abilities in both healthy and non-MS impaired populations (Mosti et al., 2014; Mosti, Kaehler, 
Stunes, Hoff, & Syversen, 2013; Piacentini et al., 2013; Østerås, Helgerud, & Hoff, 2002; Hill et 
al., 2012; Hoff et al., 2007). An MST protocol could serve as a good method of combatting the 
fatigue that often sets in with strength programs that require higher repetitions or longer time 
intervals due to its short duration and low repetitions. To date there is one study that has 
examined the use of MST in PwMS, but its relationship to functional measures was not assessed 
(Fimland, Helgerud, Gruber, Leivseth, & Hoff, 2010). The purpose of this study was to examine 
the effects of MST on gait and balance in PwMS. We hypothesized that MST would result in 
improved gait and balance measurements in PwMS, and if our hypothesis was correct, it would 
suggest that MST can be an effective means of treating functional limitations in PwMS. The null 
hypothesis for this study was that MST would not result in improved gait and balance 
measurements in PwMS. 
Use of MST in Healthy Populations 
MST was effectively utilized in non-pathological populations and resulted in 
improvements in strength, endurance, rate of force development (RFD), running economy, and 
bone mineral density (BMD) (Mosti et al, 2014; Østerås et al, 2002; Piacentini et al, 2013).  
Østerås et al. (2002) used an MST protocol to examine whether an increase in exercise economy 
was due to a change in the force-velocity relationship and mechanical power output of the 
musculoskeletal system. A group of 19 cross-country skiers were randomly assigned to an MST 
or control group. The MST group trained for 15 minutes, three times per week, for nine weeks, 
with an emphasis on increasing neural  adaptations instead of muscle hypertrophy, as supported 
by Almåsbakk and Hoff (1996), who found that the use of short, explosive movements in an 
exercise program could promote a greater increase in strength via neural adaptations compared to 
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muscle hypertrophy. The MST groups’ protocol consisted of three sets of five repetitions using 
85% of their 1RM, whereas the control group was allowed to participate in traditional strength 
endurance training only, which was defined as lifting less than 85% of their 1RM. The primary 
outcome measures for both groups were 1RM, time to exhaustion, peak power, and RFD. The 
high resistance group’s 1RM and time to exhaustion significantly increased on average by 22% 
and 61%, respectively, while peak power and RFD also increased significantly. The control 
group showed no significant differences for any primary outcome measures, allowing the authors 
to conclude that the increase in peak power and RFD rather than the increase in 1RM 
specifically, might be more responsible for the improved endurance performance.   
Mosti et al. (2014) examined the effects of MST versus general exercise 
recommendations on changes in bone mass density (BMD) and strength in young adult females. 
30 females were randomly assigned to either the MST (n=15) or control group (n=15) for the 12 
week intervention. The MST group performed 4 sets of 3-5 repetitions on a hack squat exercise 
machine, with an emphasis on an explosive concentric contraction followed by a controlled 
eccentric motion. The control group was encouraged to participate in exercise on their own time 
as recommended by the American College of Sports Medicine (ACSM). Following the 
intervention, only the MST demonstrated statistically significant improvements in BMD as 
measured by dual-energy x-ray absorptiometry of the lumbar spine and hip. In addition, the MST 
group had greater improvements in RFD and 1RM compared with the control group, with the 
authors suggesting the changes were most likely due to a more efficient neuromuscular system. 




Piacentini et al. (2013) examined the effects of a variety of strength training programs, 
including MST, over a 6 week period on master endurance runners and their performance. 
Master athletes differ from conventional or professional athletes in that they are generally older 
(e.g. 35 and older), and have busy schedules from non-running related work and/or family duties. 
MST was compared to standard resistance training (RT) and endurance training, with the 
author’s looking at the changes in 1RM, running economy, body composition, and functional 
movements such as a squat jump and countermovement jump. Both training groups performed 
multiple lower and upper extremity exercises on different days, twice a week, in addition to their 
regular running program. The MST group did 4 sets of 3-4 repetitions at 85-90% of their 1RM, 
while the RT group performed 3 sets of 10 repetitions at 70% of their 1RM. The control group 
performed only endurance training in addition to their regular running program. Following the 6 
week intervention, the MST group had the most significant changes in the areas of 1RM and 
running economy at a marathon level pace, whereas the RT group was the only one to have 
improvements in squat jump and countermovement jump. There were no changes in body 
composition following the intervention, with the author’s concluding the changes found were 
most likely due to neurological mechanisms. The positive improvements in master athletes from 
utilizing a MST program include not only a more efficient neuromuscular system, but also a 
program that can build strength for those who perform high levels of endurance exercise in a safe 
and effective way.  
Use of MST in Non-Neuropathological Populations 
MST was found to improve walking performance in non-neuropathological populations 
such as peripheral arterial disease (PAD) and chronic obstructive pulmonary disease (COPD). 
MST has also been demonstrated to be effective in restoring strength in the operative limb for 
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those undergoing total hip arthroplasties (Husby et al., 2009). Wang et al. (2010) examined the 
effects of MST on walking performance in individuals with PAD, as measured by RFD, walking 
economy, and time to exhaustion. Ten subjects with Fontaine stage II (mild) PAD were recruited 
for this nonrandomized study, and served as their own controls for eight weeks prior to 
beginning an eight week MST exercise program. The MST program consisted of a 10-minute 
warm-up on a treadmill at a patient selected speed prior to performing four sets of four 
repetitions at 85-90% of their 1RM on a horizontal leg press machine. The subjects trained three 
times a week over the eight-week period, with all patients completing the program. Following 8 
weeks of MST, there were significant improvements in the subjects’ RFD, walking economy, 
and time to exhaustion. The findings of Wang et al. (2010) were consistent with Østerås et al. 
(2002), suggesting that very high load, low repetition programs could not only increase strength, 
but also help with muscular endurance.   
Hoff et al. (2006) examined MST effects on mechanical efficiency, as measured by the 
ratio of work performed to oxygen consumption, in persons with COPD. Twelve subjects were 
chosen on the basis of fitting the clinical definition of COPD of GOLD guidelines between 40 
and 70 years of age with FEV1/FVC < 70% and FEV1 < 60%, with six subjects in the MST 
group and six subjects assigned to the control group. The MST program consisted of subjects 
performing four sets of five repetitions on a horizontal leg press machine at 85-90% of their 
1RM, three days a week. The primary outcome measures were pulmonary function, RFD, 1RM, 
and peak force. Only the MST group showed significant changes following the program, with a 
21.5% improvement in FEV1, 10% improvement in FVC, in addition to improvements of 83.2% 
in RFD, 27.1% in 1RM, and 13.4% in peak force. The measure for mechanical efficiency after 
the MST program intervention also showed statistically significant improvements of 31.3%. 
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Although this study demonstrates that  MST is well tolerated in the COPD population, similar to 
the outcome found by Wang et al. (2010), Mosti et al. (2014), and Østerås et al. (2002), 
functional measures such as gait and balance were not assessed.    
 Husby et al. (2009) compared the effects of a four week intervention using MST and 
conventional rehabilitation on patients’ one week status post total hip arthroplasty (THA) lateral 
approach versus only conventional rehabilitation on strength, RFD, gait parameters, work 
efficiency, and quality of life measurements. The MST group performed 4 sets of 5 repetitions at 
85% of their 1RM on a leg press machine and standing cable abduction exercises, as well as 
conventional rehabilitation, which included sling exercise therapy for the hip in the sagittal and 
frontal planes with sets of 12-15 repetitions. The conventional rehabilitation occurred five days a 
week for both groups, with the MST group also performing the leg press and abduction exercises 
five times a week for one hour per session. Following the intervention, the authors noted both 
groups had demonstrated improvements in their 1RM for both exercises and overall RFD, but the 
MST group had significantly greater changes. Work efficiency, which is a percentage of the total 
energy expended during a specific task, had a greater trend in the MST group at posttesting 
compared to the conventional rehabilitation group. Gait parameters and quality of life scores 
were however, not statistically significant between groups. The positive changes observed in 
subjects’ 1RM as well as trend towards a greater work efficiency during this short 4 week 
intervention likely resulted from some plastic changes in the nervous system due to the duration 
of the study. MST appears to not only be safe for patients 1 week following a THA, but also very 
effective in restoring strength during the acute to subacute phases of recovery.    
Use of MST in Neuropathological Populations 
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Examining past studies’ use of MST in neuropathological populations was important to 
support the effectiveness and safety of MST in PwMS. Criteria for the studies presented here 
were focused upon the specificity of the MST protocol. Any study that did not use a weight 
lifting protocol involving lifting 85-95% of one repetition maximum [1RM]) with four or five, 
repetitions was specifically excluded from this review, except for studies that worked with 
significant neurological populations and or whose protocol emphasized maximal strengthening 
using a different methodology. The upcoming section will present studies which looked at the 
effect of MST in persons with neuropathologies including schizophrenia, stroke, spinal cord 
injury (SCI) and MS, of whose results led to improvements in various aspects including strength, 
function, and neural drive. 
Heggelund, Morken, Helgerud, Nilsberg, & Hoff (2012) examined the effects of MST on 
walking efficiency in patients with schizophrenia. This non-randomized controlled pilot study 
consisted of 6 schizophrenic subjects participating in the MST group and 7 schizophrenic 
subjects playing computer games as the control. The study was conducted over an eight-week 
period, with supervised interventions three times a week. The MST group performed a five-
minute warm-up on a treadmill at an intensity of 70% peak heart rate before performing four sets 
of four repetitions at 85-90% of the subject’s 1RM on a leg press machine. Subjects in the MST 
group increased their 1RM by 38%, improved their mechanical efficiency of walking, a 
percentage of work input that is converted into work output, by 3.4%, and also decreased their 
VO2 cost of walking. The strength gains and improved efficiency of walking seem to indicate 
that MST could be used as an appropriate treatment for those with strength and gait deficits in 
this patient population.    
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Hill et al. (2012) examined the effectiveness of MST on lower extremity strength 
function of chronic stroke survivors. Ten subjects were included if they walked independently, 
and  if their stroke occurred more than six months prior to the study. Prior to beginning the 8 
week MST protocol, subjects served as their own control for four weeks to limit contributions 
from other sources. The MST intervention consisted of four sets of four repetitions of 85-95% of 
their 1 RM, doing unilateral plantarflexion and leg press via the horizontal leg press machine, 
three days a week. The subjects’ 1RM significantly improved in both the plantarflexion and the 
leg press exercises, with a notable 223% gain of the affected limb on the leg press. The 6 Minute 
Walk Test (6MWT), Timed Up and Go Test (TUG), and Four Square Step Test (FSST) were 
also utilized, with gains in all except the FSST. This study confirms that MST may be associated 
with significant strength gains that also can carryover into function.  
Fimland et al (2010) was the first to date to examine the effect of MST on the 1RM and 
neural drive, via EMG, in PwMS. Fourteen PwMS were recruited, pretested, and evenly 
randomized to a MST group or a control group. Both the MST and control group participated in 
conventional rehabilitation exercises (aqua gymnastics, stretching, physical therapy, and 
relaxation techniques). The MST group additionally participated in a specific MST training 
regime five times per week for three weeks. The training regime consisted of four sets of four 
repetitions at 85-90% of their 1RM of unilateral leg press and seated calf raises, similar to the 
study by Hill et al. (2009). The primary outcome measures included maximum voluntary 
isometric plantar flexor contractions (MVCs) and surface electromyography measurements 
(EMG) (Root mean square [RMS], M-wave, H-reflex, and V-wave) of the soleus muscle. The 
M-wave is the initial response to muscle stimulation, the H-reflex measures the monosynaptic 
reflex, and the V-wave is an electrophysiological variant of the H-reflex, which is supposed to 
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measure descending neural to motor neurons (Fimland et al., 2010). MVC and soleus RMS EMG 
activity increased significantly by 20% and 36%, respectively in the MST group, while no 
significant changes were seen in the control group. The MST group observed changes in the V-
wave, with the control group not measuring any EMG changes The significance of this study was 
that it was the first that showed an increase in efferent outflow to spinal motor neurons to the 
lower limb muscles in PwMS as a result of a strength-training program, as evidenced by positive 
changes in V-wave values. This suggests that there may be a unique firing pattern in the central 
nervous system that happens with MST as compared to mild and moderate strength training 
programs.   
An observational, cross sectional study by Broekmans et al (2012), further contributes to 
the theory that maximal strength, rather than submaximal, may be a stronger contributor to 
increased function (Eek et al., 2008). Broekmans et al. (2012) examined the correlation between 
modes of maximal strength contractions and the walking capacity of PwMS.  Fifty two 
participants, diagnosed with MS, were included with mild to moderate disease (scores 1.5 and 
6.5 on the Expanded Disability Status Scale [EDSS]). The different modes of maximal strength 
included maximal isometric torque, maximal isokinetic torque, and maximal isokinetic muscular 
endurance, measured via a dynamometer.  Walking capacity was measured via functional 
measures including the TUG, the Timed 25 Foot Walk Test (T25FW), and the Two Minute Walk 
Test (2MWT). Between the two subgroups, there were stronger correlations between strength 
and walking capacity in persons with moderate ambulatory dysfunction. For those with moderate 
ambulatory dysfunction, there were only significant correlations between muscle endurance and 
all walking tests. Knee-flexor isometric strength, of both subgroups, had a higher correlation 
with the walking tests than knee extensor isometric strength. Although this study did not use 
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MST, defined as 4 sets of 4-5 repetitions, lifting 85-95% of the 1 RM, it did examine the effect 
of maximal effort during exercise on functional gains in PwMS. 
Jayaraman, Thompson, Rymer, & Hornby (2013) purposefully utilized a short duration 
study to emphasize neurological gains rather than hypertrophy, which impact strength 
improvement if applied in eight weeks or less. The study compared the effects of a 4 week 
maximal intensity resistance program (MAX), utilizing isometric contractions versus a 
progressive resistive exercise (PRE) program, on functional measures in persons with chronic, 
incomplete SCI. Their methodology differed from the MST studies previously discussed in that 
they used maximal isometric contractions instead of isotonic contractions, as well as 3 sets of 10 
repetitions instead of 4 sets of 4 repetitions, but their goal was to still stress the patient’s nervous 
system at their highest level. Positive changes were noted in the BBS only in the MAX group, as 
well as improvements in 6MWT times and Modified Ashworth scores. The authors stated they 
purposefully utilized a short duration study to try and emphasize neurological gains, as the 
nervous system has been shown to have the greatest impact on strength changes in less than 8 
weeks duration. The results of this study may indicate that positive neurological changes in 
strength and functional measures could actually be seen in a variety of maximal intensity training 
programs. The common denominator in this study and the previously discussed MST studies 
reviewed appears to be maximum intensity training. A MST protocol however, may be more 
functional in that it utilizes isotonic muscle contractions, and requires extremities to move 
throughout their full ROM, whereas isometric contractions generally only result in strength 




The literature demonstrates that maximal strength training can translate into increased 
strength and improved functional measures. The study by Hill et al. (2012) used an MST 
protocol defined as 85%-95% of ones 1RM, however, other studies referenced here utilized 
varying approaches to strengthening at maximal strength. The positive effects of MST were 
observed in the aforementioned nonpathological, non-neuropathological, and neuropathological 
populations. The study by Fimland et al. (2010) is the only one to date that has examined the 
impact of MST on PwMS, but no subjective or functional measures were implemented. The 
purpose of this study was to examine the impact of MST on PwMS using functional measures, 
specifically those in gait and balance. We hypothesized that MST would result in improved gait 
and balance; therefore, it would suggest that MST could be an effective mode of treating some of 
the functional limitations present in persons with MS.  Our null hypothesis was that MST would 

















Eight subjects were recruited for this pilot study based off of flyers that were present in a 
MS specialty office, where the lead investigator currently practices. The inclusionary criteria 
consisted of a positive diagnosis of MS, the ability to ambulate for 6 minutes with or without an 
assistive device, and the ability to understand and sign an informed consent form. Exclusionary 
criteria included any type of orthopedic or cardiopulmonary condition restricting the ability to 
walk for 6 minutes, any exacerbations, either immediately prior (2 weeks or less) or during the 
study, or any cognitive issues that would prevent them from following instructions on how to 
perform the exercises and tests.  
       The demographics of the subjects included the years since the MS diagnosis, their EDSS, 
age, gender, medications (if any), if they use an assistive device (AD), baseline fatigue according 
to the Fatigue Severity Scale (FSS), and fatigue before and after each session, as determined by 
the Visual Analog Fatigue Scale (VAFS). The EDSS is the most widely used scale for PwMS in 
determining their level of impairment (Amato & Ponziani, 1999; Kurtzke, 2008). The FSS has 
also been verified as an accurate method of measuring fatigue in PwMS (Learmonth et al., 2013). 
The VAFS has been successful in measuring fatigue on a daily basis, as opposed to the FSS, 
which is a better indicator of fatigue over longer periods of time (Shah, 2009; Flachenecker et 
al., 2002).     
Design 
              The design of this study used a similar protocol to that of Hill et al. (2012), which 
examined the effects of MST in chronic stroke survivors. Each subject performed four sets of 
four repetitions at 85-95% of their 1RM using a horizontal leg press machine, two days per 
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week, over the course of an 8 week training period. The 1RM, the Berg Balance Scale (BBS), 
and 6MWT were the primary outcome measures, with the VAFS and FSS used as secondary 
subjective measurements.  
All sessions took place at Hunter College’s Physical Therapy department, with the lead 
investigator and at least one student physical therapist present during each participant’s session. 
During the first session, the BBS and 6MWT were used to establish baseline values. Both have 
been verified as reliable tests to assess balance and endurance in PwMS (Cattaneo, Regola, & 
Meotti, 2006; Goldman, Marrie, & Cohen, 2008). The BBS was performed first to avoid 
significantly fatiguing subjects, and a five minute rest period was given after each test to allow 
for adequate recovery. To determine each subject’s 1RM, subjects were first familiarized with 
the horizontal leg press machine and set up with their hips and knees aligned at 90 degree angles. 
Once in proper alignment, subjects began with minimal weight while performing unilateral leg 
press extensions in order to gain comfort in performing the exercise. The load was then increased 
to a level that the subject felt was about 50-75% of their maximum capacity.  Single repetitions 
were performed with increasing weight (5-10 lbs) until only 1 repetition could be completed. The 
single repetition was determined as their 1RM. This protocol has been previously performed with 
PwMS in a study by Fimland et al. (2010) and is recommended by the American College of 
Sports and Medicine (2013). This concluded the initial visit and baseline assessment.  
For the 8 week intervention, an aerobic warm-up was performed for 5 minutes on a cycle 
ergometer at a comfortable pace as decided by the subject. After completion of the warm-up, five 
minutes of rest were given to normalize blood pressure, and then subjects performed a muscular 
warmup of five repetitions on the leg press machine at 50% intensity of their 1RM. 90 seconds 
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after the muscular warmup, subjects began the MST regimen, consisting of 4 sets of 4 repetitions 
at 85-95% of their 1RM for each leg, with 90 second breaks in between sets.  
Subjects were instructed to perform an explosive concentric contraction followed by a 
slower controlled eccentric contraction, such that the time spent was in a 1:2 time ratio, 
respectively. Subjects were also told to pause a full second before performing the next repetition 
to avoid elastic energy contribution to the movement, and instructed not to hold their breath in 
order to prevent the Valsalva maneuver from occurring. The Valsalva maneuver causes a 
significant increase in intraabdominal and intrathoracic pressure, which would assist in the lift, 
but could potentially lead to a significant decrease in blood pressure and syncope. If subjects 
were able to perform all 4 sets of 4 repetitions at the designated weight, and felt they could 
perform a fifth repetition, the weight was increased by 2.5-5 lbs at the next session, with the 
increase determined by subject capability and clinical judgment of the researchers.  
At the end of each session of four sets of four repetitions, a cool down was performed on the 
cycle ergometer for five minutes. Fatigue was measured using the VAFS before and after the 
MST regimen in each session, with the FSS filled out on a weekly basis. Scheduling varied for 
each participant over their 8 week program, but there was at least one day of complete rest before 
returning for the second session of the week. At the end of the eight week training program, 
subjects performed each of the individual outcome measures including, 6MWT, BBS, and 1RM 
test, concluding the experimental portion of the study. If any of the subjects were uncomfortable 
or felt the need to stop for any reason at any point during a session, the session would have 
ended. If more than one incident occurred, or if an exacerbation developed, the participant would 





Analyses were performed with SPSS version 12.0 (SPSS, Chicago, IL).  Mean values were 
calculated for all variables and participant characteristics. The statistical analysis used in the 
study was a repeated-measures multivariate analysis of variance (MANOVA) was conducted.  
Because the repeated-measures MANOVA involved just two levels of repeated measures, the 
assumption of sphericity was not relevant to this analysis. Due to the small sample size, 
bootstrapping (using a replication sample of 1000) was employed; bootstrapping is a relatively 
common statistical procedure in MS studies, including clinical trials, with small samples 
(Humphreys, Drummond, Phillips, & Lincoln, 2013; Palacios, Alonso, Bronnum-Hansen, & 
Ascherio, 2011; Saxton et al., 2013).  A p-value of 0.05 was used to determine if the results are 
significant.  This repeated-measures MANOVA was used for each variable including the 6MWT 
time, BBS scores, 1RM, FSS, and VAFS. Each subject was asked to fill out a VAFS before and 
after each session. VAFS consists of a 10 cm horizontal line with written descriptions at each 
end; subjects were asked to mark on the line the point that they feel represents their perception of 
their current state of fatigue. The possible score ranges from 0 to 100, measured in millimeters 
on a 10 cm vertical line using a pen (Tseng, Gajewski, & Kluding, 2010). The changes in the 
VAFS scores throughout each subjects training protocol was tested for significance using 




Demographics and Subject Characteristics 
Eight subjects participated in the study and seven completed the MST training protocol. 
Initially, one subject dropped out due to unrelated reasons.  Second, one of the remaining seven 
participants completed only 7 out of the 8 weeks of the MST protocol due to scheduling 
complications. Four subjects completed all 16 MST training sessions, two subjects completed 
15MST training sessions, and one subject completed 14 MST training sessions.  This means 
subjects completed 96.43% of training.  Of the subjects who completed the training, the mean 
age was 51.57 years (+12.74, range 34-69 years), the mean number of years since diagnosis was 
14.29 years (+14.29, range 3-35 years), mean EDSS was 3.57 (+1.23, range 2.5-6), and mean 
MSIS29 was 69.14 (+18.44, range 43-92).  Two subjects were male; five were female.  Five 
subjects walked with an assistive device; four used anti-fatigue medications, and three used anti-
spasticity medication.  These values are summarized in Table 1. 




EDSS Score, mean (SD) x̅ 3.57, range 2.5-6 (+1.23) 




Taking Anti-fatigue Meds 4 
Taking Anti-spasticity Meds 3 
MSIS29 Score, mean (SD) x̅ 69.14, range 43-92 (+18.44)  
Years since dx, mean (SD) x̅ 14.29, range 3-35 years (+11.67) 
Table 1:  Demographics and Clinical Characteristics of Participants (n=7) 
MS, Multiple Sclerosis; EDSS, Expanded Disability Status Scale; MSIS29, Multiple Sclerosis Impact Scale; RR, 
relapsing-remitting; SP, secondary progressive; PP, primary progressive 
 
One Repetition Maximum (1RM) Scores 
All results were analyzed using a group mean average of pre and post testing 1RM 
measurements. Right sided 1RM significantly increased from pretest (M = 146.07, SD = 93.36) 
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to posttest (M = 228.93, SD = 95.98), F(1,6) = 20.26, p = .004, partial η2 = .772 (Figure 1). This 
was an increase of 82.86 pounds in right sided leg strength. Left sided 1RM increased even more 
significantly from pretest (M = 142.86, SD = 100.87) to posttest (M = 215.00, SD = 114.07), 
F(1,6) = 63.03, p < .001, partial η2 = .913 (Figure 1). This was an increase of 72.14 pounds in 
left sided leg strength.   
Individual 1RM pre to post test measurement values are represented in the tables and 
figures below (Table 2, Table 3, Figure 2, Figure 3, Figure 4) 
 
One Repetition Maximum (1RM): Right Lower Extremity (lbs) 
Subject # Pre-Test Post-Test 1RM Change in 
lbs 
1RM Change in % 
1 100 220 +120 +120% 
2 145 267.5 +122.5 +84.5% 
4 60 75 +15 +25% 
5 85 180 +95 +112% 
6 325 395 +70 +22% 
7 95 230 +135 +142% 
8 212.5 235 +22.5 +11% 
Table 2: Pre & Post Test Right Leg One Repetition Maximum (Individual Values & Percent Increases); 1RM, One 
Repetition Maximum 
 
One Repetition Maximum (1RM): Left Lower Extremity (lbs) 
Subject # Pre-Test Post-Test 1RM Change in 
lbs 
1RM Change in % 
1 30 62.5 +32.5 +108% 
2 170 272.5 +102.5 +60% 
4 125 177.5 +52.5 +42% 
5 80 150 +70 +87.5% 
6 325 420  +95  +29% 
7 75 167.5 +92.5 +123% 
8 185 255 +70 +38% 






Figure 1: Pre & Post Test Unilateral Strength Change (Group Mean Values); 1RM, One Repetition Maximum 
 
 







































Figure 3: Pre & Post Test Right Leg 1RM (Individual Values); 1RM, One Repetition Maximum 
 
 
Figure 4: Pre & Post Test Left Leg 1RM (Individual Values); 1RM, One Repetition Maximum 
Week-by-Week Differences Regarding IRM 
Bootstrapped Friedman’s tests were conducted to determine if the amount of weight (in 
pounds) lifted (using both the right and left leg) significantly increased in increments over the 
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and 2.  The first Friedman test analyzed incremental weight increases for the right leg for weekly 
session 1 and was found to be significant, χ²(7) = 48.13, p < .001.  The amount of weight (in 
pounds) that participants lifted significantly increased incrementally over the eight-week study 
period.  The mean amount of weight lifted using the right leg during weekly session 1 
significantly increased from M = 131.07 (SE = 31.73) at week 1 to M = 169.29 (SE = 31.81) at 
week 8 (Figure 5). 
 
Figure 5: Weight (in pounds) lifted using right leg (Session 1) 
 
The second Friedman test assessed incremental weight increases for the left leg for 
weekly session 1. Results were significant, χ²(7) = 47.28, p < .001.  The amount of weight (in 
pounds) that participants lifted significantly increased incrementally over the eight-week study 
period.  The mean amount of weight lifted using the right leg during weekly session 1 
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significantly increased from week 1 (M = 127.43, SD = 33.19) to week 2 (M = 133.93, SE = 
31.51), dropped to M = 123.57 (SE = 37.54) at week 3, but then continued to increase 
incrementally over the eight weeks, ending at week 8 with an M = 159.64 (SE = 33.53) (Figure 
6). 
 
Figure 6: Weight (in pounds) lifted using left leg (Session 1) 
 
Incremental increases in weight (in pounds) lifted using the right leg during weekly 
session 2 were examined in the third Friedman test, which was found to be significant, χ²(7) = 
47.21, p < .001.  This significance, however, was influenced by an outlier at week 3 (Figure 7).  




Figure 7: Weight (in pounds) using right leg (Session 2) 
 
Results from the Friedman test remained significant when data from the third week were 
removed, χ²(6) = 41.22, p < .001.  The amount of weight (in pounds) that participants lifted 
significantly increased incrementally over the eight-week study period.  The mean amount of 
weight lifted using the right leg during weekly session 2 significantly increased incrementally 





Figure 8: Weight (in pounds) using right leg (Session 2) with week 3 data removed 
 
The fourth and final bootstrapped Friedman test analyzed incremental weight increases 
for the left leg for weekly session 2, and results were significant, χ²(7) = 47.81, p < .001.  The 
amount of weight (in pounds) that participants lifted significantly increased incrementally over 
the eight-week study period.  The mean amount of weight lifted using the left leg during weekly 
session 2 significantly increased from week 1 (M = 129.57, SE = 87.65) to week 8 (M = 161.07, 




Figure 9: Weight (in pounds) using left leg (Session 2)  
6 Minute Walk Test (6MWT) Scores    
All results were analyzed using a group mean average of pre and post testing 6MWT 
measurements. There were significant increases in total distance walked, measured in feet, from 
pretest (M = 1040.04, SD = 429.25) to posttest (M = 1190.73, SD = 579.95), F(1,6) = 6.35, p = 
.045, partial η2 = .514.6 (Figure 10). 6MWT scores improved 150.69 feet following the 8 week 
MST protocol.  
Individual 6MWT pre to post test measurement are represented in the tables and figures 






6 Minute Walk Test (6MWT) Individual Pre and Post Test Results (ft) 
Subjects Pre-Test Post-Test 6MWT Change in 
ft 
6MWT Change in 
% 
1 553 474.8 -78.2 -14% 
2 732.1 799.1 +67 +9% 
4 1071 1188.4 +117.4 +11% 
5 1389.3 1680.6 +291.3 +21% 
6 1733.1 2103 +369.9 +21% 
7 1162.3 1373.6 +211.3 +18% 
8 681.3 742.1 +60.8 +9% 
Table 4: Pre & Post Test 6MWT (Individual Values & Percent Increases); 6MWT, Six Minute Walk Test 
 
 


















Figure 11: Pre & Post Test 6MWT (Individual Values); 6MWT, Six Minute Walk Test 
Group 6MWT minute-by-minute measurements were recorded but were not analyzed for 
significance (Table 5). 
 
 
Table 5: Minute-by-Minute Pre & Post Test 6MWT (Group Mean Values); 6MWT, Six Minute Walk Test 
 
Berg Balance Scale (BBS) Scores 
All results were analyzed using a group mean average of pre and post testing BBS scores. 
There were significant pre- (M = 44.29, SD = 8.34) to posttest (M = 49.57, SD = 5.83) increases 
in balance, as measured by the Berg Balance Scale (BBS), F(1,6) = 15.56, p = .008, partial η2 = 
.722 (Figure 12).  BBS scores improved 5.3 points following the 8 week MST protocol.  
Individual BBS pre to post test scores are represented in the tables and figures below 













6 Minute Walk Test (6MWT)
Pre Test
Post Test
Pre & Post Group 6MWT – Mean Minute by Minute Comparison (in ft) 
  1 2 3 4 5 6 
Average 
Pretest 184.19 365.85 539.46 707.39 879.32 1046.02 
Average 
Posttest 202.63 458.9 611.31 805.1 1004.73 1194.51 
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Berg Balance Scale (BBS) 
Subjects Pre-Test Post-Test BBS Change 
1 31 39 +8 
2 46 49 +3 
4 36 48 +12 
5 54 56 +2 
6 52 55 +3 
7 48 53 +5 
8 43 47 +4 
Table 6: Pre & Post Test BBS (Individual Values); BBS, Berg Balance Scale 
 
 

















Figure 13: Pre & Post Test BBS (Individual Values); BBS, Berg Balance Scale 
 
Week-by-Week Differences in Fatigue Scores  
A series of bootstrapped Friedman tests were conducted to determine if participants’ 
fatigue scores incrementally increased over the eight-week study period.  Participant fatigue was 
assessed using the Fatigue Severity Scale (FSS) and the Visual Analog Fatigue Scale (VAFS).  
Fatigue as measured by the VAFS was examined at pretest and posttest for sessions 1 and 2.    
            The first bootstrapped Friedman test analyzed data from the FSS, and results were not 
significant, χ²(7) = 13.15, p = .068.  The FSS fatigue scores ranged from a low of M = 44.00 (SE 
= 5.86) (at week 1) to a M = 53.00 (SE = 3.03) (at week 7).  The FSS scores remained around M 
= 48.50 for the remaining weeks.  
A series of bootstrapped Friedman tests were then conducted on the VAFS, with analyses 
conducted on pretest and posttest scores for Sessions 1 and 2.  Results from the bootstrapped 
Friedman test for pretest VAFS scores at session 1 were not significant, χ²(7) = 6.24, p = .512.  
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13.08) at week 2.  After week 2, however, the fatigue scores did not vary much from M = 41.00, 
the exceptions being M = 49.00 during weeks 6 and 7.  The bootstrapped Friedman test 
conducted on the VAFS posttest scores for session 1 furthermore showed that fatigue did not 
demonstrate any significant incremental increases over the eight-week study period, χ²(7) = 
11.64, p = .113.  The week 1 mean was 39.80 (SE = 6.64), which increased to M = 52.60 (SE = 
8.43) at week 2.  After week 2, fatigue scores started to incrementally decline.  While fatigue 
peaked during weeks 6 and 7 (with Ms of 55.00 and 59.80, respectively), the final week 8 mean 
fatigue score of 52.60 (SE = 4.97) was the same as the mean for week 2.  
A bootstrapped Friedman test was then conducted on the VAFS pretest scores for session 
2, and it was found to be non-significant, χ²(7) = 5.88, p = .554.  The VAFS fatigue scores 
increased from M = 20.00 (SE = 9.50) at week 1 to M = 25.33 (SE = 12.41) at week 2, but the 
fatigue scores did not vary much from a mean of 25.00 for the remaining weeks, the exception 
being week 5, in which the mean was 38.67 (SE = 3.18), resulting from an outlier.  The 
bootstrapped Friedman test conducted on the VAFS posttest scores for Session 2 was not 
significant, χ²(7) = 5.10, p = .647.  While fatigue increased from M = 37.67 (SE = 2.33) at week 
1 to M = 50.00 (SE = 3.00), after week 2 the fatigue scores actually began to incrementally 
decrease.  The fatigue mean score of M = 38.33 (SE = 8.09) at week 8 was very similar to the 








The present study hypothesized that an eight week MST protocol would result in 
improved gait and balance measurements in PwMS. Our hypothesis was supported by significant 
increases, represented by a group average, for all individual variables (1RM, BBS, and 6MWT) 
following the MST protocol.  Clinically, these results support the idea that therapists can utilize 
maximal intensity training in PwMS to improve function in a safe and effective manner. In the 
past, PwMS have been directed away from intensive exercise due to the fear of exacerbating 
their fatigue, a significant symptom of MS. Not only did the participants demonstrate increases 
in their 1RM and their functional outcomes, but there were no incidents of exacerbation or 
injury, and no significant increases in fatigue throughout the study. The increase in subjects’ 
1RM, post MST training, were statistically significant, as they were in the initial MST study by 
Fimland et al. (2010). The present study is the first, to the authors’ knowledge, to link these 
significant changes in 1RM,  following an MST protocol, to functional gains in balance and gait 
(BBS and 6MWT) in PwMS.   
Both clinical and statistical significance in functional measures were observed between 
pre and post test outcomes measures. Clinically significant changes were seen in two subjects 
who increased their 6MWT distance by 250 feet or more, and 2 subjects who increased their 
BBS scores by 7 points or more. All subjects demonstrated statistically significant increases in 
their 1RM at the conclusion of the eight week protocol. Statistically significant changes occurred 
in BBS scores and 6MWT distances group averages. No significant increases occurred in fatigue 
as measured using the VAFS and FSS. Possible reasons for these promising outcomes in this 
pilot study will be discussed.  
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MST – Changes in Neural Drive 
In regards to strength improvements, the factor believed to be primarily responsible for 
changes in subjects’ 1RM was improvement in neural drive, as opposed to muscle hypertrophy, 
due to the limited duration of the exercise intervention. (Aagaard, Simonsen, Andersen, 
Magnusson, & Dyhre-Poulsen, 2002). Neural drive has been previously defined as “the ensemble 
of action potentials from a group of alpha motor neurons to the innervated muscle” (Farina & 
Negro, 2012). With strength training, the increases in neural drive can influence the activation of 
muscles through modulation or changes in motor unit recruitment, synchronization, firing 
frequency, and inter-muscular coordination (Cormie et al., 2011). These neural changes are seen 
earlier in a strengthening protocol unlike muscle hypertrophy, which is a slower process. It 
generally takes at least six weeks to develop noticeable increases in cross sectional area, making 
it unlikely to account for the large gains seen throughout this study’s protocol (Guilhem, Cornu, 
& Guével, 2010; Folland, & Williams, 2007; Phillips, 2000). Even with changes in the muscle 
fibers themselves, these changes were likely supplementary to the increased neural drive that 
occurred throughout the exercise program. As previously defined, MS is a degenerative 
neurological disease that results in the demyelination of axons and formation of inflammatory 
plaque in the central nervous system (CNS) (Frohman, Racke, & Raine, 2006). It is a possibility 
that this demyelination and plaque development could lead to a decrease in neural drive, which 
would make MST an important type of exercise to consider, as it has been shown to improve 
neural drive in both non-neuropathological, and neuropathological populations (Hill et al. 2012; 
Hoff et al. 2006; Fimland et al 2010; Østerås et al. 2012; Mosti et al. 2014; Piacentini et al. 2013; 
Wang et al. 2010). Fimland et al. (2010), utilized MST on PwMS, to increase neural drive during 
a 3 week MST protocol and found increases in maximum voluntary contraction (MVCs) and 
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surface EMG measurements via the V-wave of the soleus muscle pre to post MST intervention in 
PwMS, indicating increased neural drive. Resistance training, in general, results in increased 
motor unit firing frequency, which is correlated with a 300-1500% increase in force output 
during ballistic contraction (Cormie et al, 2011). Increases in neural drive may be the factor that 
links the strength gains seen in MST with improvement in function, as evidenced by the positive 
changes in functional measures. This improvement in function is an overarching physical therapy 
goal and MST may be effectively utilized in PwMS in attaining these goals.  
CLINICAL IMPLICATIONS 
Improved Function 
The increase in lower extremity strength following the MST protocol was coupled with 
functional improvements displayed by significant improvements on the BBS and the 6MWT. 
This is a very substantial finding as improvements in function could impact quality of life to a 
greater extent than an objective improvement in leg strength alone. The ability to show a possible 
link between strength gains from an MST protocol with improvements in gait and balance 
measurements could have a positive impact on the possibilities for treatment in PwMS. The 
question then arises, why does a static intervention such as a unilateral leg press have a possible 
carryover into dynamic functional activities like the BBS and 6MWT?  The BBS is an objective 
measure that focuses on postural control of an individual while the 6MWT is a measurement that 
focuses primarily on gait endurance. Postural control and gait endurance are separate entities 
requiring different neural mechanisms in order to perform each effectively. Possible neural 
mechanisms for the improvements in the BBS and 6MWT include changes in rate of force 
development and increase in work efficiency.  
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Modulation of neural drive could play a role in the improvement on the BBS. One factor 
influenced by increased neural drive is known as rate of force development (RFD).  RFD has 
been defined as the rate of rise of contractile force at the beginning of a muscle action (Aagaard 
et al., 2002). RFD, is considered functionally important in situations where the time to develop 
force is limited, such as restabilization of the body following a loss of balance (Tillin et al. 
2012). The BBS is a measure of a subject's ability to maintain postural control throughout 
various static and dynamic tasks. Some of the tasks on the BBS are time sensitive and require a 
subject to complete a dynamic task within a specific time in order to receive a score of 4/4. For 
example, one of the items on the BBS requires the subject to turn around in a full circle, pause, 
then turn around in a full circle in the opposite direction. In order to achieve a 4/4 score, each full 
turn must be completed in 4 seconds or less. Another item on the BBS requires the subject to 
place each foot alternately on a step/stool until each foot has touched the step/stool 4 times. In 
order to achieve a 4/4 score, the 8 touches must be completed in 20 seconds or less. An improved 
RFD could influence a subject's ability to perform these dynamic tasks within the specified time. 
As the time to complete such a task decreases, the time to develop the appropriate force becomes 
more important.  If the RFD can be directly influenced through a MST protocol of the lower 
extremities, this may be a factor that accounts for the functional improvement seen on the BBS. 
The increases seen in the 6MWT for this study could have occurred due to a variety of 
mechanisms. Walking occurs at a rather typical pace that is energy efficient; if you walk slower 
or faster than this rate, energy expenditure increases as a result of a loss of potential energy and 
momentum (Nolan, Yarossi, & Ramanujam, 2013; Waters & Mulroy, 1999). In many 
neurological pathologies, such as MS, gait is significantly altered in terms of kinematics and 
kinetics, thus resulting in increased energy use to perform this task. During endurance 
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performances it is generally thought that by spending as little energy as possible at a given speed, 
an individual can either save energy or increase speed and thus improve the endurance 
performance (Heggelund et al. 2013). Resistance training has been shown to improve work 
economy and endurance performance, although the exact variables responsible are unknown 
(Aagaard and Andersen 2010). It does however, appear that maximal strength and RFD coincide 
with improved work economy, which could have functional implications (Sunde et al. 2010). 
Heggelund et al. (2013) found that MST using heavy loads and explosive performance improved 
work economy by 31% in untrained and moderately trained men. In other words, an individual 
will have the ability to perform more or the same amount of work with reduced effort following 
an MST protocol.  
Hip and knee extensors are the primary muscles used when performing a leg press and 
are important for gait (Heggelund et al. 2013). Increasing their ability to generate force may have 
contributed to faster ambulation speed because these muscles are important in ambulation, and 
became more fatigue resistant to the task of walking (Heggelund et al. 2013). In this case, the 
quality of gait may not have drastically changed, but their ability to perform the task may have 
been less taxing on their system because they were able to use relatively less energy to perform 
the task. The results of this study demonstrate that PwMS respond similarly to MST with 
improvement in work economy as seen with the changes in the pre and post 6MWT results.  
Another reason for the positive findings in functional measures from this study may have 
resulted from strengthening weak or untrained muscles necessary for dynamic activities such as 
gait and balance. This addresses the premise that correcting impairments will translate into 
improved performance of functional measures. This contrasts with task specific training, which 
holds that training responses/adaptations are tightly coupled to the mode, frequency, and duration 
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of the exercise performed (Hawley, 2002). This means that the vast majority of training-induced 
adaptations may have only occurred  in those muscle fibers that have been recruited during the 
exercise regimen, with little or no adaptive changes occurring in untrained musculature. 
Furthermore, the principle of specificity predicts that the closer the training routine is to the 
requirements of the desired outcome, the better will be the outcome (Hawley, 2008). This idea, 
however, did not seem to hold true with the results of our protocol, as MST utilizing a unilateral 
leg press appears to be an impairment based strengthening intervention. Yet, even with an 
impairment based strengthening protocol, we found significant improvements in functional 
measures following the MST protocol. A potential reason why a task specific training approach 
may not be ideal for the MS population is that it requires a basic level of strength and functioning 
to even attempt to perform the task successfully. Since the MST protocol utilized in this study 
focused on the hip and knee extensors, muscles essential for gait, their ability to generate force 
more efficiently may have been the reason for the possible carryover into function, as objectively 
seen with the BBS and 6MWT results. The conventional leg press machine is not task specific, 
and does not appear to have any objective correlation to gait and balance.  
Safety 
One of the most important aspects of any physical exercise program is that it is safe for 
the participant, and with neurological conditions such as MS, it is imperative that patients are 
managed appropriately by a skilled professional who understands their diagnosis and what is in 
their best interest. Because of the significant weight utilized for MST, it may appear to be unsafe 
for those with pathological conditions due to the stresses placed on the body, and only 
appropriate for athletes and younger conditioned individuals. MST has been a successful 
exercise protocol in the healthy and athletic populations, causing significant strength gains, 
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improved exercise endurance, and improvements in functional measures (Mosti et al., 2014; 
Østerås et al., 2002; Piacentini et al., 2013; Symons, Vandervoot, Rice, Overend, & Marsh, 
2005). However, MST has also been shown to be safe and effective in neurological and non-
neurological disabled populations (Hill et al., 2010; Hoff et al., 2006;  Karlsen, Helgerud, 
Støylen, Lauritsen, & Hoff, 2009; Mosti, Kaehler, Stunes, Hoff, & Syversen, 2013; Wang et al., 
2010). For our study, there were no adverse orthopedic events or reported neurological changes 
during the performance of the intervention, confirming with other cited studies that MST is a 
safe exercise protocol for use in a variety of patient populations. Only one subject dropped out of 
the study due to a knee injury following a fall while getting out of bed. Since PwMS are at an 
increased falls risk, the fall may have been an incidental finding, and not necessarily due to the 
exercise protocol (Matsuda et al., 2011). This is an important finding of the study, as it adds to 
the current body of evidence suggesting that maximal, high intensity resistance training, along 
with typical submaximal resistance training, does not appear to have any relationship to MS 
symptom exacerbations, and is in fact beneficial for PwMS (Pilutti, Platta, Motl, & Latimer-
Cheung, 2014; Roppolo, Mulasso, Gollin, Bertolotto,& Ciairano, 2013; Sutherland & Andersen, 
2001).  
 One of the reasons why the MST protocol using the horizontal leg press machine was 
safe for PwMS may have been due to its implementation in a controlled, supervised 
environment. The horizontal leg press was set up with hip and knee angles at approximately 90 
degrees, and their feet shoulder width apart with slight external rotation at the ankles. The slight 
inclination that is present with the horizontal leg press machine puts the spine in a more neutral 
alignment, and mimics the squatting motion throughout the range of motion. The handle bars at 
the side of the machine also allowed for subjects to maintain greater stability when performing 
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the exercise through the range, further contributing to the safety of the leg press. These factors, 
as well as having at least two members of the research group present, ensured that subjects were 
consistently set up properly before and during each session, and allowed for monitoring and 
discussion with subjects about potential issues or complaints. Under a supervised and controlled 
environment, there does not appear to be any contraindications to performing MST using a 
horizontal leg press machine for PwMS. As long as subjects are appropriately screened, setup, 
and monitored by skilled professionals, this is a safe intervention that could be utilized in PwMS.  
Lastly, the use of MST without appropriate staffing and supervision may not be unsafe 
depending on the person and their level of independence. For example, one of our subjects’ final 
1RM was 395 pounds. He was independent with all activities and may be able to utilize this in a 
gym setting without help. In contrast, there were subjects who required assistive devices to 
ambulate and needed help getting onto the leg press machine. For these individuals, it would not 
be advised to perform this outside of a clinical setting. The widespread use of MST in the 
physical therapy and/or strength and conditioning realm would thus be limited depending on the 
environment of the clinic or gym, the knowledge of the clinician(s), and appropriate staffing. The 
general time frame to perform MST also needs to be considered, as it takes about 20-25 minutes 
to complete, which may or not be feasible for certain offices along with all other necessary 
treatments. 
Fatigue 
Measuring the potential impact MST has on fatigue is important as it is a prevalent 
symptom in PwMS (Flachenecker et al, 2002). The two subjective fatigue outcome measures 
utilized included the Visual Analog Fatigue Scale (VAFS), which measured short term fatigue, 
and the Fatigue Severity Scale (FSS), which looked at more chronic effects of fatigue over a 
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period as long as week (Flachenecker et al., 2002; Shah, 2009). MS related fatigue has been 
defined as “A subjective lack of physical and/or mental energy that is perceived by the individual 
or caregiver to interfere with usual and desired activities.” (Multiple Sclerosis Council for 
Clinical Practice Guidelines, 1998). Exercise induced fatigue as defined in the non-MS 
population, has been defined as “any exercise-induced reduction in the capacity to generate force 
or power output” (Vøllestad, 1997). Both fatigue types affect PwMS and are difficult to 
objectively differentiate, however participants’ report of feeling less fatigued after MST sessions 
is a promising indication.  
An important reason for choosing maximal strength training as an intervention for PwMS 
is its short duration, which may avoid fatigue (Karpatkin et al, 2012). Karpatkin et al. 
demonstrated that intermittent ambulation demands on PwMS were less fatigue inducing than 
continuous ambulation, we hypothesized that MST, which is a strength protocol of short duration 
and consistent 90 second breaks between sets, will not exacerbate fatigue.  A unique 
characteristic of the MST protocol is that it is very short in duration and very high in intensity 
compared to traditional resistance exercise programs, which use moderate repetitions and 
intensity values. MST at 85-95% of their 1 RM requires a participant to do 4 repetitions each set 
while submaximal training may require anywhere between 8-15 repetitions per set, at a weight 
that enables this many repetitions. A submaximal training program that requires more repetitions 
is more time consuming, and is more likely to elicit time dependent fatigue. Fatigue is the most 
common symptom for PwMS, it should therefore be a goal of clinicians to limit this occurrence 
whenever possible to maximize their ability to participate in exercise, as well as to perform daily 
activities. Ambulation for example, requires alternating flexion and extension contractions across 
joints, however, with the onset of neuromuscular fatigue comes the inefficient co-contraction of 
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muscles, limiting gait (Ranieri & Di Lazzaro, 2012). The MST protocol in this study used a total 
of only 21 repetitions per leg in each session, including the warm-up, lasting less than 20 minutes 
of actual weight lifting of loads at maximal intensities (85-95% of their 1RM). This suggests that 
the work performed, even with lower repetitions, could be similar or greater than programs with 
lower loads and greater repetitions, but over a much shorter period of time. The short nature of 
MST and the 90 second rest period in between sets, may avoid the onset of neuromuscular 
fatigue and allow patients to work on more efficient flexion and extension patterns, which may 
have contributed to their faster walking speed evidenced by increased 6MWT times and better 
balance as evidenced by increased BBS scores. One of the mechanism by which MST works for 
PwMS, is that it may avoid fatigue due to limits exercise duration time, while allowing them to 
reap the benefits of a rigorous MST program.  
 The purpose of conducting the intervention during the winter months was to decrease the 
chances of causing heat induced fatigue, common in PwMS (Cantor, 2010). Heat can 
significantly alter one's level of fatigue, and limit their ability to perform their typical and desired 
activities. Exercising by its very nature results in increased body temperature, and this has led to 
the finding that temperature increases with exercise may increase their perception of fatigue, 
limiting their ability to participate in exercise programs (Sutherland et al., 2001). This theory 
however, is not consistent with research examining the effects of exercise on PwMS. Petajan et 
al. (1996) for example, demonstrated that PwMS could not only tolerate aerobic exercise, but 
benefit from its effects physiologically and psychologically, as evidenced by increases in aerobic 
capacity, strength in both their lower and upper extremities, and positive changes in their quality 
of life. Due to the insignificant increase in reported fatigue by our subjects we can add to the 
research that supports that integrating strength training into the treatment plan for PwMS is a 
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means of maintaining strength, endurance, participation in activities of daily living, and 
promoting psychological health (Motl & Pilutti, 2012). 
Psychological Impact 
The psychological profiles of many PwMS may be affected from the initial discovery of 
their diagnosis, including the onset of depression and a perception of limited abilities, including 
the inability to exercise and receive its benefits (Roppolo et al., 2013; Kasser & Kosma, 2012; 
Jensen, Molton, Gertz, Bombardier, & Rosenberg, 2012). As a result of inactivity from 
psychological changes, there may be significant functional changes that could negatively affect 
their quality of life. This may include difficulty ambulating inside and outside the home, 
transferring from various surfaces, limited working hours due to fatigue and weakness, as well as 
sexual and/or hygienic issues (Sutherland et al., 2001). Therefore, symptoms of depression 
should be addressed to help mitigate secondary changes that could occur. Two recent review 
articles discussed the effects of exercise on depression, with both studies indicating that exercise 
may have the potential to provide a reduction in depressive symptoms (Dalgas,, Stenager, Sloth, 
& Stenager, 2014; Ensari, Motl, & Pilutti, 2014). This is an important finding, as exercise can 
serve not only as a means to improve strength and lead to improvements in functional measures 
as shown in the present study using MST, but also as a way to reduce and/or mitigate depressive 
symptoms. MST can then, be safely utilized as an appropriate exercise program that could 
address the depressive issues PwMS may experience. Psychological measures were however, not 
utilized in the present study, limiting the direct effects MST may have had on psychological 
profiles. 
In our study, many subjects were extremely surprised from the initial evaluation to the 
end of the study at how much weight they were able to lift using each leg on the horizontal leg 
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press. The general comments that were made by the subjects reflected perceptions of overall 
weakness because of their diagnosis of MS. These responses from the subjects were consistent 
throughout the study, and suggest the possibility of a psychological component in their ability to 
lift heavy weights and exercise regularly. The clinical implication from this is that clinicians 
treating PwMS should not assume one is weak or cannot perform a specific task just because 
they have MS. Their perceptions of what they can and cannot do may be misaligned with reality 
for a number of reasons, requiring the clinician to investigate the cause of such thoughts and 
thoroughly assess their ability to perform specific tasks. In addition, seeing progression with the 
weight lifted throughout the study as well as having a regular exercise program may have 
contributed to a positive perception of their abilities to perform high intensity exercises, and thus 
improvement in the functional areas examined. 
Spasticity 
Considering whether spasticity would impact participants during the MST intervention 
was important since it affects 40-60% of PwMS (Beard et al, 2003). In addition, participants in a 
study by Balantrapu et al (2014), demonstrated that participants with higher levels of spasticity 
had lower 6MWT, TUG, and timed 25 foot walk (T25FW) scores. Spasticity is an upper motor 
neuron sign and is observed as hyperexcitability of the stretch reflex (Mukherjee, 2010). 
Spasticity has been documented to be more responsible for causing lower extremity disability 
rather than decreased strength (Beard et al, 2003). If this is the case, than strengthening spastic 
lower extremities may not be contraindicated, as long as this UMN sign is not elicited mid 
intervention. 
Spasticity is elicited by passive/static stretching of muscles as well as dynamic muscle 
stretch by muscle and tendon jerks (Mukherjee, 2010). MST utilizing a leg press machine 
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demands an active ballistic extension of the hips, knees, and ankles which through reciprocal 
inhibition, inhibits firing of muscles on the opposite side of the joint, and causes them to undergo 
a “passive” quick stretch, which potentially could elicit upper motor neuron signs. “Hyperactive 
stretch reflexes may be elicited easily in an antagonistic spastic muscle and thus impede the 
initiation or execution of agonist movement” (Nielson et al, 2006). However although we did not 
measure spasticity during the intervention, via observation or participant report, spasticity was 
not an apparent symptom in most participants. Any UMN signs that were observed were during 
the 90 seconds in between sets and did not interrupt the completion of the protocol. Instances of 
clonus were detected during two separate sessions, and LE extensor spasms were regularly noted 
between sets in one participant however, the spasms faded within 90 seconds until the next set 
and did not seem to affect his ability to complete the program. Although triggers of spasticity 
include excess heat, fatigue, pain, or physical and/or emotional stress, it appears that voluntary 
maximal effort utilized in MST does not elicit spasticity and may compete with it, by distracting 
the nervous system, so to speak. (Phadke, Balasubramanian, Ismail, & Boulias, 2013) If this is 
so, this may help explain the significant increases in strength, and limited symptoms of 
spasticity. It may also be that the reorganized CNS that occurred due to increased neural drive 
resulted in plastic CNS changes that limited the expression of UMN signs. Outside of the 
incidents of spasticity mentioned above, no other upper motor neuron lesion signs were apparent 







LIMITATIONS TO MST STUDY 
Our study is subject to a number of limitations. The present study was a pilot study with a 
sample size of only seven subjects. Initially, one of the original 8 participants dropped out of the 
study due to unrelated reasons. Second, one of the remaining seven participants completed only 7 
out of the 8 weeks of the MST protocol due to scheduling complications. It is noted that due to 
the small sample size, it is difficult to generalize the results found in the study across the MS 
population. However, due to the unpredictable and variable presentation of the disease, 
increasing sample size alone may not necessarily improve the generalizability of the research. 
Since there is no stereotypical presentation of PwMS, other variables must be taken into 
consideration that may help generalize these results. Specifically, although the sample size was 
small, the variability in demographics in terms of EDSS score, age, clinical presentation and 
years since diagnosis may have  helped offset the smaller sample size.  
Selection bias was another limitation due to the convenience sample that was used as all 
subjects were former patients and/or subjects of the research advisor and have participated in 
prior research concerning MS. As convenience samples are inherently non-randomized, it is 
unlikely that the sample was representative of the entire studied population. Furthermore, prior 
knowledge of MS-related research and relationship with the research advisor may have 
contributed to biasing subjective measurements such as the VAFS and FSS, which were used to 
quantify fatigue. Despite the inherent pitfalls that may be associated with a convenience sample, 
due to the time constraints and limited financial resources, this method of sampling seemed to 
the best alternative for the study.  
In PwMS, fatigue is divided into MS-related fatigue and exercise-induced fatigue. Braley et 
al. (2010) stated that the most commonly proposed contributors to MS-related fatigue are 
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associated with the immune system and the central nervous system. Specifically, the influence of 
proinflammatory cytokines, hormonal imbalances, axonal demyelination and degeneration, and 
altered patterns of cerebral activation are thought to contribute to MS-related fatigue. As 
discussed above, the VAFS and FSS, which are subjective measures, were used to quantify 
fatigue - an objective phenomenon. Due to the unpredictable nature of the disease and the 
subjective outcome measures utilized, it was difficult to differentiate whether the VAFS and FSS 
measurements depicted increases in MS fatigue or exercise-induced fatigue.   
Another limitation of the study is that outdoor temperature and humidity cannot be 
controlled. As elevated temperatures and humidity have negative effects on persons with MS, 
data collection was not performed during the summer months. However, despite conducting 
experimental sessions outside summer months, there was still variability in weather conditions 
such as precipitation and extreme cold that may have affected the patients’ fatigue levels prior to 
sessions. To offset the variability of the outside temperatures, subjects were given 10-minute rest 
periods prior to the beginning of each session; furthermore, objective measures were taken in 
indoor hallways and all leg press protocols were completed in the same gym where temperature 
was controlled. Variability in time of day subjects performed protocol was also a limitation. As 
researchers and subjects had to accommodate respective schedules, the time of day for all 
subjects were not standardized as some subjects were only available in the evenings (after having 
worked an entire day) and others preferred mornings/early afternoons.  
One of the outcome measures utilized for the study was the BBS, which is a clinically 
accepted tool of quantifying balance in association with risk of falls. However, the BBS 
inherently has a floor / ceiling effect that makes it a limitation. Specifically, a 56/56 on the BBS 
does not indicate that the subject has a zero falls risk. Downs, Marquez, & Chiarelli (2013), 
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noted that the floor or ceiling effects occur when the majority of the subjects score close to zero 
or perfect on the test, which make it difficult to detect whether the change in balance was due to 
the experimental intervention. For example, in the study, one patient had nearly a perfect score 
during pre-testing. In persons with extremely good balance where most of the items are scored 
4/4, the scale is unlikely to detect a change in balance even if there was one (Downs et al., 2013). 
Another limitation was in determining 1RM. Although there was a standardized protocol in 
obtaining a subject’s 1RM, there was a great deal of individual variability in obtaining this 
outcome measure. Obtaining each subject’s 1RM required that the subjects start at an arbitrary 
weight and incrementally (anywhere from 5 lbs up to 50 lbs) increase to the weight until only 
one repetition can be performed with maximal effort. As subjects had varying levels of strength, 
the increments that were increased were based upon clinical judgment, patient’s feedback, and 
successful completion of the leg press. Attempts to obtain a 1RM during both pre and post-test 
measures also varied.  The number of attempts exceeded 10 times and unfortunately, with so 
many attempts, one must consider the onset of exercise induced fatigue, especially in PwMS. 
The challenge was determining how to minimize the number of attempts, which would require 
greater weight increases.  Using a dynamometer to assess force output may be worthy of 
considering not only because it will decrease chances of fatigue but also because voluntary 
activation during maximal dynamic contractions has been shown to be significantly lower than 








Future research should first address the aforementioned limitations. Specifically, a larger, 
randomized sample size would be more generalizable and representative of the MS population. 
Furthermore, the present study looked at impairment (reduced strength) and utilized the MST 
protocol to hypothesize that an increase in strength measured by 1RM would translate into 
improved gait and balance. This study provided potential mechanisms for the improvements in 
strength, as well as the functional measures of gait and balance, but these are still only inferences 
based on the current literature and the study’s findings. By further investigating the possible 
causes of the results found in this study in these different domains, clinicians will be able to 
better prescribe exercise that focus on the goal of the individuals. As mentioned, the study did 
not include any task specific measures, suggesting that having strong antigravity muscles such as 
hip and knee extensors play a significant role in performing static and dynamic tasks. Future 
research should look at MST’s effect on task-specific outcome measures  such as stair climbing, 
as done by Symons, Vandervoot, Rice, Overend, & Marsh (2005)  to further quantify MST’s 
effect on function. 
Future research should also include a measure of balance without a ceiling effect as this was 
one limitation of the study. The ceiling effect limits the ability to objectively measure balance 
improvements in subjects who had pretest scores of close to 56. A possible alternative would be 
to incorporate the Mini-BESTest balance test as it not only minimizes the ceiling effect found in 
the BBS but also incorporates aspects of the Timed Up and Go (TUG), Dynamic Gait Index 
(DGI), and the BBS. King, Priest, Salarian, Pierce, & Horak (2012) looked at the effectiveness of 
the Mini-BESTest versus the BBS specifically in persons with Parkinson’s Disease (PD). As in 
PD, postural instability and balance deficits are significant impairments in persons with MS. 
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King et al., (2012) noted that the high sensitivity of the Mini-BESTest is especially valuable as it 
does a better job at picking up mild deficits in balance compared to the BBS; thus providing 
neuromuscular intervention strategies earlier on in the disease progression.  
Applying an outcome measure for upper motor neuron signs  is suggested.  In order to see 
whether there is a statistically significant correlation between the MST protocol and increased 
upper motor signs such as spasticity, an outcome measure may include the Modified Ashworth 
Scale (MAS), as applied by Jayaraman, Thompson, Rymer, & Hornby (2013) in their study of 
the effect of MST on persons with incomplete spinal cord injuries. 
Other outcome measures to take into account are gait characteristics by quantitative gait 
analysis. Temporal-spatial parameters such as stride length, step length, cadence and kinematic 
parameters such as joint angles can be measured physically before and after an MST protocol to 
determine improvement in function (Cerny, 1983). As a proper gait pattern with improved gait 
mechanics would translate into increased efficiency and thus, decreased motor/exercise-induced 
fatigue, quantitative gait analysis should be implemented in future research. 
The method used in determining 1RM may have been a limitation in this study due to the 
large amount of individual variability in number of attempts to reach 1RM. This may be 
addressed by utilizing an isokinetic dynamometer to measure force output. This would allow for 
a standardized number of attempts for maximal volitional contraction of the tested muscle(s) in 
order to then correlate it with changes in force output after a strengthening protocol has been 
implemented.  
Finally, the MST intervention may also be utilized in future protocols isolating muscle 
groups that are important during gait such as the hamstrings, gluteus medius, gluteus maximus 
and gastroc/soleus complex, as these muscle groups are essential to gait and balance. 
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Strengthening these specific muscle groups in isolation may translate into larger improvements 
in balance and gait measures, which will undoubtedly change/add to the approach in 
























 Despite the aforementioned limitations, this study provides evidence that MST in PwMS 
resulted in statistically significant improvements in their 1RM, 6MWT times, and BBS scores. 
These positive findings were associated with no significant changes in fatigue, which supports 
the use of MST in the clinical setting for PwMS. It is important to note that with appropriate 
supervision and proper body mechanics utilizing the leg press-machine, the MST protocol 
implemented was safe. Although all the subjects in this study reported feeling better and stronger 
after each session, further research should be conducted to specifically look at the link between 
MST and psychological impact in persons with MS. Future studies will need to implement MST 
with an increased sample size looking at balance measures with less ceiling effects, quantitative 
gait analysis, maximal-contraction force outputs, and/or isolating the MST protocol to key 






























APPENDIX A: TYPES OF MULTIPLE SCLEROSIS 
(Taken verbatim from The National Multiple Sclerosis Society) 
 
Relapsing-remitting MS (RRMS) 
RRMS — the most common disease course — is characterized by clearly defined attacks of 
worsening neurologic function. These attacks — also called relapses, flare-ups or 
exacerbations — are followed by partial or complete recovery periods (remissions), during 
which symptoms improve partially or completely and there is no apparent progression of 
disease. Approximately 85 percent of people with MS are initially diagnosed with relapsing-
remitting MS. 
 
Secondary-progressive MS (SPMS) 
The name for this course comes from the fact that it follows after the relapsing-remitting 
course. Most people who are initially diagnosed with RRMS will eventually transition to 
SPMS, which means that the disease will begin to progress more steadily (although not 
necessarily more quickly), with or without relapses. 
 
Primary-progressive MS (PPMS) 
PPMS is characterized by steadily worsening neurologic function from the beginning. 
Although the rate of progression may vary over time with occasional plateaus and 
temporary, minor improvements, there are no distinct relapses or remissions. About 10 
percent of people with MS are diagnosed with PPMS. 
 
Progressive-relapsing MS (PRMS) 
PRMS — the least common of the four disease courses — is characterized by steadily 
progressing disease from the beginning and occasional exacerbations along the way. People 
with this form of MS may or may not experience some recovery following these attacks; the 





APPENDIX B: CONSENT TO PARTICIPATE AS A RESEARCH SUBJECT  
 
Hunter College 
Program in Physical Therapy 
City University of New York 
Consent to Participate as a Research Subject 
  
Investigators: 
Janet Dworetsky, SPT 
David Park, SPT 
Charlie Wright, SPT 
Michael Zervas, SPT 
Faculty Advisor: 
Herbert I. Karpatkin, PT, DSc., NCS, MSCS, Associate Professor at Hunter College  
Hunter College, Program in Physical Therapy 
425 East 25th Street, N.Y., N.Y. 10010  
212-481-5051 
  
Purpose and Background 
You are invited to participate in a research study. The study is conducted under the direction of 
Dr. Herbert Karpatkin, PT D.Sc., associate professor at Hunter College in the Physical Therapy 
Department.  Janet Dworetsky, David Park, Charlie Wright, and Michael Zervas are doctoral 
students in the Physical Therapy Program at Hunter College.  The purpose of this research study 
is to examine the effects of maximal strength training (MST) on gait and balance in persons with 
multiple sclerosis (MS).  You are being asked to participate in a study that will help determine if 
MST is an effective exercise program for treating symptoms in MS patients. You were selected 
for participation because you are a person with MS over 18 years of age, walks as a regular 
means of transportation, and can perform exercises using a horizontal leg press machine.  There 
will be an anticipated 30 subjects that will participate in this study. Your participation in this 
study is voluntary. You may choose to withdraw from the study at any time.   
Procedures 
Patients will perform testing individually. You will perform four sets of four repetitions on a 
horizontal leg press machine at 85-95% of your one repetition maximum (1RM). The study will 
take place at the Physical Therapy Department at Hunter College, 425 East 25th Street, N.Y, 
N.Y., 10010, over the course of an 8 week period. Each session will last approximately 45 




The study procedures in detail are as follows: 
 
 If you agree to be a subject, you will complete a questionnaire with the researchers to determine 
if you are eligible for the study. The screening will ask questions about your medical history 
including length of time with MS, medications, use of assistive devices for walking such as 
canes, walkers, or splints, and whether you have a history of non-MS complications such as a 
heart condition or orthopedic problems. The researchers will also look at information from your 
medical records such as your Expanded Disability Status Scale Score (EDSS). 
 If your responses indicate that you are eligible, you will be asked to participate in this study.  If 
you are not eligible to participate, the information obtained from you during screening will be 
omitted from this study and shredded to protect your privacy. 
 Once identified as an eligible subject, you will be asked to schedule a time to meet with Dr. 
Karpatkin and two to four of the collaborating physical therapy students. 
 At that scheduled time, you will come to the Physical Therapy Department at Hunter College. 
During the first visit, you will participate in the 6 minute walk test (6MWT), and Berg Balance 
Scale (BBS) test, prior to beginning the MST program. These tests will be repeated at the end of 
the 8 week period. 
 On the same day you will also be familiarized with the horizontal leg press machine at a very 
low weight until comfortable, at which point the poundage will be increased to a level you feel is 
about 50-75% of your maximum capacity. Single repetitions will be performed with increasing 
weight (5-10 lbs) until only 1 repetition can be completed. This single repetition will be 
determined as your 1RM. 
 A warm-up will be performed during each session, and will consist of either 5 minutes on a 
treadmill or cycle ergometer. Following this, you will perform 5 repetitions at 50% of your 1RM. 
This will conclude the warm-up. 
 The MST exercise protocol will consist of 4 sets of 4 repetitions at 85-95% of your 1RM per 
visit. Once you are able to do more than 4 repetitions in a single set, the weight will increase by 
5-10 lbs, with your feeling of capability guiding the exact weight increase. 
 After each set, you will take at least a 90 seconds rests prior to starting the next set. 
 A cool-down of 5 minutes will be performed on either a treadmill or cycle ergometer, concluding 
the session. 
 The total time expected for each session is approximately 45 minutes, with the first and last 
session taking longer due to the inclusion of the 6MWT and BBS tests. 
  
  
None of the procedures or questionnaires in this study is experimental. The only experimental 
aspect of this study is the gathering of information for the purpose of analysis. 
  
  
Risks and/or Discomfort 
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There are minimal risks to you from participation in this study. You may experience some 
fatigue-related discomfort and delayed onset muscle soreness as a result of the exercise protocol. 
Because fatigue is the most common symptom in persons with MS, it is important to note that 
any fatigue experienced may be characteristic of the disease itself, as opposed to a result of the 
testing conditions. The soreness the results in the days following exercising is normal and to be 
expected. You will have at least 24 hours rest in between exercise sessions. The strength training 
protocol of this study is not expected to worsen your fatigue, or any other aspect of your MS in 
any way. Dr. Karpatkin will be beside you for the entire exercise duration, including the 6MWT 
and BBS tests. Despite these safeguards, there is a chance that you could incur an orthopedic 
injury from the horizontal leg press machine or that you may fall and sustain an injury at the 
facility. If this should occur we will immediately contact your primary care physician and if 
necessary take you to the emergency room. 
  
If you are feeling bothered or upset as a result of participation, or for any reason wish to not 
continue you may simply ask to stop and we will immediately end the procedure. You will be 
free not to answer any item in any of the questionnaires or forms. 
  
Benefits 
There may be no direct benefits to you as an individual. This may increase your gait and balance 
levels, and how they may vary based on different exercise protocols. 
 
Voluntary Participation: Your participation in this study is voluntary, and you may decide not 
to participate without prejudice, penalty, or loss of benefits to which you are otherwise entitled.  
If you decide to leave the study, please contact the research coordinator, Dr. Karpatkin, to inform 
him of your decision. 
 
Alternatives 
The alternative to this study is nonparticipation without repercussions or penalties. 
  
Financial Considerations 
Other than the cost of travel to and from the Physical Therapy Department at Hunter College, 
there are no costs incurred by you for participation in the study.  
  
Confidentiality 
The data will be collected using the two fatigue surveys that you fill out, measuring the distance 
walked within the three trials, and the change in 1RM.  Strict confidentiality will be maintained.  
Knowledge of your identity and participation in this study will be limited to Dr. Karpatkin, the 
collaborating physical therapy students, and IRB members and staff.  Information about your 
participation will only be disclosed in the event of an emergency requiring hospitalization, and in 
such a case will be disclosed to the treating hospital physician and your primary care physician.  
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Under expected non-emergency circumstances, no individual identifying information about you 
will be disclosed.  Where possible, all identifying references about you will be removed and 
replaced by a numeric code. Participation in this research is voluntary and involves minimal loss 
of your privacy. All questionnaires and data about you that will be used in computer analyses 
will have number codes rather than your name. Your name will not be recorded on the 
information or reported in any scientific paper or professional meeting to protect your identity. 
All data will be reported in aggregate (group) fashion at a professional meeting or in a scientific 
journal so that no one can identify any information about you. If data are used for a publication 
in the medical literature or for teaching purposes, no names will be used. A master list of code 
numbers as well as all other data pertaining to you and other subjects will be kept confidential by 
the researchers and will be stored in a locked file cabinet in the faculty research advisor’s office.  
Data that will be used for computer analyses will be kept on a flash drive and only researchers 
involved in this study and representatives of the IRB members and staff will have access to the 
records and information about this study. All original hardcopy data will be shredded seven years 
after completion of the study. The code key connecting names to numbers will be kept in the 
research office of Dr. Karpatkin. Confidentiality will be maintained to the extent allowed by law. 
  
Withdrawal 
You may terminate your participation from this study prior to the start or at any time during the 
study without penalty, repercussion, or loss of compensation. 
  
Contact Information 
If you have questions about the study, you can contact Dr. Karpatkin, at 212-396-7115.  You 
should contact the Hunter College Human Research Protection Program (HRPP) Office at (212) 
650-3053, if you have questions regarding your rights as a subject or if you feel you have been 
harmed as a result of your participation in this research. 
  
Signatures 
I have read (or have had read to me) the contents of this consent forms and have been 
encouraged to ask questions.  I have received answers to my questions.  I have received answers 
to my questions. I give my consent to participate in this study.  I have received (or will receive) a 
copy of this form for my records and future references. 
  
 
______________________         ___________________________       ___________ 
Participant’s Name                       Signature                                              Date 
  
  
_______________________         ___________________________       ___________ 
Researcher’s Name                       Signature                                              Date 
55 
 
 APPENDIX C: SUBJECT DEMOGRAPHIC INFORMATION  
 
Subject Demographic Information 
 
Age: __________           Gender: M  /  F     Date of Birth: __________________ 
Type of Multiple Sclerosis:  _______________________________________________________ 
Year since diagnosis of Multiple Sclerosis:  __________________________________________ 
Expanded disability status scale (EDSS) Score: ____________________ 
Fatigue Severity Scale (FSS) Score:  ____________________ 
Use of assistive device: __________________________________________________________ 
Use of anti-spasticity medications:  _________________________________________________ 




1. Are you able to walk unassisted for 6 minutes with or without an assistive device? 
YES    NO 
2. Do you have any orthopedic, cardiovascular, or pulmonary issues that would be 
compromised by talking or prohibit you from walking? 
YES    NO 
3. Are you able to read and comprehend an informed consent document? 
YES    NO 
4. Have you had evidence of an exacerbation in the past 4 weeks as determined by a 
neurologist? 
YES    NO 
5. Have you received Methylprednisone treatment in the past 4 weeks? 
YES    NO 
6. Do you have difficulty following simple commands? 





APPENDIX D: FATIGUE SEVERITY SCALE (FSS)  
 
 
Fatigue Severity Scale (FSS) 
 
Your Name             
 




This questionnaire contains nine statements that rate the severity of your fatigue symptoms.  
Read each statement and circle a number from 1 to 7, based on how accurately it reflects your 
condition during the past week and the extent to which you agree or disagree that the statement 
applies to you. 
 
***A low value (e.g. 1) indicates strong disagreement with the statement, whereas a high value 
(e.g. 7) indicates strong agreement. 
 
During the past week, I have found that:                 Disagree             Agree 
 
1. My motivation is lower when I am fatigued        1   2   3   4   5   6   7       
 
2. Exercise brings on my fatigue.       1   2   3   4   5   6   7       
 
3. I am easily fatigued.        1   2   3   4   5   6   7       
 
4. Fatigue interferes with my physical functioning.     1   2   3   4   5   6   7       
 
5. Fatigue causes frequent problems for me.      1   2   3   4   5   6   7       
 
6. My fatigue prevents sustained physical functioning.    1   2   3   4   5   6   7       
 
7. Fatigue interferes with carrying out certain duties and responsibilities.  1   2   3   4   5   6   7          
 
8. Fatigue is among my three most disabling symptoms.    1   2   3   4   5   6   7          
 
9. Fatigue interferes with my work, family or social life.    1   2   3   4   5   6   7          
 
 




APPENDIX E: MULTIPLE SCLEROSIS IMPACT SCALE (MSIS-29) 
 
Multiple Sclerosis Impact Scale (MSIS-29) 
 The following questions ask for your views about the impact of MS on your day-to-day life 
during the past two weeks  
 For each statement, please circle the one number that best describes your situation  
 Please answer all questions  
In the past two weeks, how much has 










1. Do physically demanding tasks? 
 
1 2 3 4 5 
2. Grip things tightly (e.g. turning on 
taps)? 
1 2 3 4 5 
3. Carry things? 
 
1 2 3 4 5 
 
In the past two weeks, how much have 










4. Problems with your balance? 
 
1 2 3 4 5 
5. Difficulties moving about 
indoors? 
1 2 3 4 5 
6. Being clumsy? 
 
1 2 3 4 5 
7. Stiffness? 
 
1 2 3 4 5 
8. Heavy arms and/or legs? 
 
1 2 3 4 5 
9. Tremor of your arms or legs? 
 
1 2 3 4 5 
10. Spasms in your limbs? 
 
1 2 3 4 5 
11. Your body not doing what you 
want it to do? 
1 2 3 4 5 
12. Having to depend on others to 
do things for you? 
1 2 3 4 5 
 
 
Please check that you have answered all the questions before going on to the next page 
®2000 Neurological Outcome Measures Unit, 4th Floor Queen Mary Wing, NHNN, 




APPENDIX F: DATA COLLECTION SHEETS  
 
Pre and Post Test Results 
 





          Berg Balance 
Scale(BBS)    Six Minute Walk Test(6MWT)    One Rep Maximum(1RM) 
Subjects Pre-Test Post-Test Pre-Test Post-Test Pre-Test Post-
Test 
1       
2       
3       
4       
5       
6       
7       
8       
9       
10       
11       
12       
13       
14       





























Warm up completed :  Aerobic          Muscular  






Weight used 1st set   Repetitions completed     
Weight used 2nd set Repetitions completed     
Weight used 3rd set Repetitions completed     
Weight used 4th set Repetitions completed     
 
Cool down completed :  Aerobic           
Patient able to tolerate more weight?: Yes   No   
Backrest setting:_______________ 
 
Day 2            
 
Warm up completed :  Aerobic          Muscular  





Weight used 1st set   Repetitions completed     
Weight used 2nd set Repetitions completed     
Weight used 3rd set Repetitions completed     
Weight used 4th set Repetitions completed     
 
Cool down completed :  Aerobic            








Date:  ____________ 
Temperature:  _________ 








Date:  ____________ 
Temperature:  _________ 





 Pre Test Results 
ITEM DESCRIPTION    SCORE (0-4) 
Sitting to standing     ________ 
Standing unsupported    ________ 
Sitting unsupported     ________ 
Standing to sitting               ________ 
Transfers      ________ 
Standing with eyes closed    ________ 
Standing with feet together    ________ 
Reaching forward with outstretched arm  ________ 
Retrieving object from floor    ________ 
Turning to look behind    ________ 
Turning 360 degrees     ________ 
Placing alternate foot on stool   ________ 
Standing with one foot in front   ________ 
Standing on one foot     ________ 
Total       ________ 
 
Post Test Results 
ITEM DESCRIPTION    SCORE (0-4) 
Sitting to standing     ________ 
Standing unsupported    ________ 
Sitting unsupported     ________ 
Standing to sitting               ________ 
Transfers      ________ 
Standing with eyes closed    ________ 
Standing with feet together    ________ 
Reaching forward with outstretched arm  ________ 
Retrieving object from floor    ________ 
Turning to look behind    ________ 
Turning 360 degrees     ________ 
Placing alternate foot on stool   ________ 
Standing with one foot in front   ________ 
Standing on one foot     ________ 





Date:  ____________ 
Temperature:  _________ 
Humidity:  __________ 
 
Date:  ____________ 
Temperature:  _________ 















1 Repetition Maximum 
 




1st attempt           1 rep max:_________________ 
2nd attempt 85% 1 rep max:_____________ 
3rd attempt 90% 1 rep max:_____________  








1st attempt     1 rep max:______________ 
2nd attempt   





Date:  ____________ 
Temperature:  _________ 
Humidity:  __________ 
 
Date:  ____________ 
Temperature:  _________ 















6 Minute Walk Test 
 




Distance after 1” 
Distance after 2” 
Distance after 3” 
Distance after 4” 
Distance after 5” 
Distance after 6” 
 




Distance after 1” 
Distance after 2” 
Distance after 3” 
Distance after 4” 
Distance after 5” 
Distance after 6” 
 
Date:  ____________ 
Temperature:  _________ 
Humidity:  __________ 
 
Date:  ____________ 
Temperature:  _________ 




APPENDIX G: DATA TABLES 
 








Diagnosis MS Diagnosis EDSS Medications 
Assistive 
Device MSIS-29 
1 2014 62 F 21 SPMS 6 
Modafinil, 
Ampyra Walker, Cane 81 
2 2014 44 M 3 PPMS 3 
Tizanidine, 
Ampyra, 
Amatidine Cane 92 
4 2014 69 F 35 SPMS 3 None Cane, AFO 54 
5 2014 62 F 4 SPMS 3 Ampyra FES 80 
6 2014 34 M 5 RRMS 2.5 Baclofen None 54 
7 2014 45 F 19 SPMS 3 Ampyra 
Walk Aide, 
FES 43 
8 2014 45 F 13 RRMS 4.5 Baclofen Cane 80 
Table 7: Subject Demographics & Characteristics 
MS, Multiple Sclerosis; EDSS, Expanded Disability Status Scale; FSS, Fatigue Severity Scale; RR, relapsing-remitting; 
SP, secondary progressive; PP, primary progressive; 6MWT, 6 Minute Walk Test 
 
   
 
             One Repetition Maximum (1RM) per Subject and Week (lbs) 
Subject # 1 Session One Session Two 
Week Right Leg Left Leg Right Leg Left Leg 
1 90 27.5 95 27.5 
2 95 27.5 100 27.5 
3 105 30 110 32.5 
4 115 35 120 37.5 
5 122.5 40 122.5 40 
6 127.5 42.5 132.5 45 
7 132.5 45 135 45 
8 137.5 45 140 47.5 
1RM Change   +50 +20 
Table 8: 1RM Weekly Changes in Weight (Subject #1); 1RM, 1 Repetition Maximum 
 
Subject # 2 Session One Session Two 
Week Right Leg Left Leg Right Leg Left Leg 
1 130 152.5 130 152.5 
2 135 157.5 140 162.5 
3 147.5 170 155 177.5 
4 150 177.5 155 182.5 
5 160 187.5 165 192.5 
6 172.5 197.5 177.5 202.5 
7 182.5 207.5 187.5 217.5 
8 190 215 192.5 217.5 
1RM Change   62.5 65 









Subject # 4 Session One Session Two 
Week Right Leg Left Leg Right Leg Left Leg 
1 55 112.5 55 117.5 
2 50 122.5 55 122.5 
3 55 122.5 57.5 127.5 
4 57.5 127.5 57.5 130 
5 60 132.5 62.5 132.5 
6 62.5 132.5 62.5 132.5 
7 62.5 132.5 62.5 135 
8 62.5 135 65 135 
1RM Change   +10 +22.5 
Table 10: 1RM Weekly Changes in Weight (Subject #4); 1RM, 1 Repetition Maximum 
 
Subject # 5 Session One Session Two 
Week Right Leg Left Leg Right Leg Left Leg 
1 75 72.5 80 75 
2 85 80 90 82.5 
3 90 85 95 90 
4 100 95 NT NT 
5 105 100 110 100 
6 115 100 117.5 102.5 
7 120 105 122.5 105 
8 125 105 127.5 105 
1RM Change   +52.5 +32.5 
Table 11: 1RM Weekly Changes in Weight (Subject #5); 1RM, 1 Repetition Maximum 
 
Subject # 6 Session One Session Two 
Week Right Leg Left Leg Right Leg Left Leg 
1 292.5 292.5 295 295 
2 297.5 300 300 302.5 
3 302.5 302.5 305 302.5 
4 305 302.5 307.5 302.5 
5 310 305 310 305 
6 312.5 307.5 315 307.5 
7 317.5 307.5 317.5 307.5 
8 320 310 322.5 310 
1RM Change   +30 +17.5 
Table 12: 1RM Weekly Changes in Weight (Subject #6); 1RM, 1 Repetition Maximum 
 
Subject # 7 Session One Session Two 
Week Right Leg Left Leg Right Leg Left Leg 
1 85 67.5 90 72.5 
2 95 77.5 97.5 80 
3 97.5 80 100 80 
4 102.5 82.5 105 82.5 
5 110 87.5 NT NT 
6 115 92.5 120 97.5 
7 120 100 125 102.5 
8 130 105 135 110 
1RM Change   +50 +42.5 








Subject # 8 Session One Session Two 
Week Right Leg Left Leg Right Leg Left Leg 
1 190 167 192.5 167 
2 197.5 172.5 NT NT 
3 200 175 205 177.5 
4 210 182.5 212.5 185 
5 215 190 217.5 192.5 
6 222.5 197.4 225 200 
7 225 202.5 227.5 202.5 
8 NT NT NT NT 
1RM Change   +37.5 +35 








































Six Minute Walk Test (6MWT) Pre and Post Test 
        








Min 4 Min 5 Min 6 Min 1 Min 2 Min 3 Min 4 Min 5 Min 6 Min 
1 
103 204 303 383 463 553 93.6 167.6 244.7 309.9 394.6 474.8 
103 101 99 80 80 90 93.6 74 77.1 65.2 84.7 80.2 
2 
138.1 273.7 398.3 513.1 624 732.1 146.6 286.1 421.9 532.4 676.2 799.1 
138.1 135.6 124.6 114.8 110.9 108 146.6 139.5 135.8 110.5 113.8 122.9 
4 
174.8 351 530 705 888 1071 187.2 418 616.1 816.1 1004.3 1188.4 
174.8 176.8 179 175 183 183 187.2 230.8 198.1 200 188.2 184.1 
5 
259 504.3 723.1 939.1 1159.9 *1389.3 279.5 578.9 864 1154.6 1436.9 
*1680.
6 
259 245.3 218.8 216 220.8 229.4 279.5 299.4 285.1 290.6 282.3 243.7 
6 
293.1 582.4 866.9 1156.7 1465.8 *1733.1  355.9 715 1066.3 1414 1757 *2103 
293.1 289.3 284.5 289.8 309.1 267.3 355.9 359.1 351.3 347.7 343 346 
7 
 207 404.9 597.1 782.8 974.6 1162.3 233.7 464.3 689 912.1 1141.7 
 
1373.6 
207 197.9 192.2 185.7 191.8 187.7 233.7 230.6 224.7 223.1 229.6 231.9 
8 
113.8 240.4 357.8 472.1 579.9 681.3 121.9 582.4 377.2 496.6 622.4 742.1 
113.8 126.6 117.4 114.3 107.8 101.4 121.9 132.2 123.1 119.4 125.8 119.7 































Weekly Subject Fatigue Severity Scale (FSS) Scores 
Subject # Week 1 Week 2 Week 3 Week 4 Week 5 Week 6 Week 7 Week 8 
1 58 59 51 56 60 62 55 57 
2 55 61 59 59 50 51 61 60 
4 23 34 27 29 29 32 50 30 
5 60 62 63 63 63 63 62 63 
6 28 49 43 40 49 48 44 49 
7 33 36 36 36 41 42 42 44 
8 51 45 52 49 48 53 58 N/A 
Table 16: Weekly FSS Scores (Individual Values); FSS, Fatigue Severity Scale 
 
Average FSS Scores 








Table 17: Average FSS Scores (Individual Values); FSS, Fatigue Severity Scale 
 
Visual Analog Scale of Fatigue Scores (VASF) per Subject and Week (mm) 
 Subject #1 Session One Session Two 
Week VASF pre VASF post VASF change VASF pre VASF post VASF change 
1 29.00 42.00 +13.00 21.00 30.00 +9.00 
2 64.00 78.00 +14.00 20.00 21.00 +1.00 
3 38.00 40.00 +2.00 61.00 63.00 +2.00 
4 31.00 33.00 +2.00 39.00 48.00 +9.00 
5 56.00 60.00 +4.00 44.00 47.00 +3.00 
6 50.00 54.00 +4.00 N/A N/A N/A 
7 72.00 76.00 +4.00 46.00 58.00 +12.00 
8 47.00 55.00 +8.00 73.00 83.00 +10.00 
Table 18: VAFS Weekly Scores (Subject #1); VAFS, Visual Analog Fatigue Scale 
 
 Subject #2 Session One Session Two 
Week VASF pre VASF post VASF change VASF pre VASF post VASF change 
1 50.00 51.00 +1.00 30.00 37.00 +7.00 
2 28.00 29.00 +1.00 47.00 47.00 0.00 
3 44.00 44.00 0.00 32.00 36.00 +4.00 
4 47.00 47.00 0.00 41.00 43.00 +2.00 
5 44.00 46.00 +2.00 44.00 44.00 0.00 
6 42.00 46.00 +4.00 20.00 25.00 +5.00 
7 57.00 63.00 +5.00 26.00 26.00 0.00 
8 38.00 35.00 -3.00 27.00 27.00 0.00 









 Subject #4 Session One Session Two 
Week VASF pre VASF post VASF change VASF pre VASF post VASF change 
1 22.00 30.00 +8.00 29.00 42.00 +13.00 
2 34.00 47.00 +13.00 25.00 47.00 +22.00 
3 59.00 71.00 +12.00 24.00 34.00 +10.00 
4 12.00 22.00 +10.00 30.00 36.00 +6.00 
5 30.00 49.00 +19.00 33.00 41.00 +8.00 
6 49.00 58.00 +9.00 23.00 33.00 +10.00 
7 24.00 39.00 +15.00 34.00 41.00 +7.00 
8 56.00 64.00 +8.00 34.00 54.00 +20.00 
Table 20: VAFS Weekly Scores (Subject #4); VAFS, Visual Analog Fatigue Scale 
 
 Subject #5 Session One Session Two 
Week VASF pre VASF post VASF change VASF pre VASF post VASF change 
1 62.00 56.00 -6.00 59.00 54.00 -5.00 
2 75.00 64.00 -11.00 55.00 55.00 0.00 
3 63.00 53.00 -10.00 54.00 48.00 -6.00 
4 70.00 63.00 -7.00 NA NA NA 
5 63.00 56.00 -7.00 68.00 59.00 -9.00 
6 62.00 55.00 -7.00 66.00 61.00 -5.00 
7 69.00 65.00 -4.00 67.00 62.00 -5.00 
8 63.00 59.00 -4.00 60.00 55.00 -5.00 
Table 21: VAFS Weekly Scores (Subject #5); VAFS, Visual Analog Fatigue Scale 
 
 Subject #6 Session One Session Two 
Week VASF pre VASF post VASF change VASF pre VASF post VASF change 
1 2.00 20.00 +18.00 1.00 34.00 +33.00 
2 2.00 45.00 +43.00 4.00 56.00 +52.00 
3 13.00 44.00 +31.00 16.00 57.00 +41.00 
4 25.00 47.00 +22.00 11.00 37.00 +26.00 
5 7.00 35.00 +28.00 39.00 63.00 +24.00 
6 42.00 62.00 +20.00 15.00 39.00 +24.00 
7 26.00 56.00 +30.00 27.00 65.00 +38.00 
8 16.00 50.00 +34.00 9.00 34.00 +25.00 
Table 22: VAFS Weekly Scores (Subject #6); VAFS, Visual Analog Fatigue Scale 
 
 Subject #7 Session One Session Two 
Week VASF pre VASF post VASF change VASF pre VASF post VASF change 
1 25.00 25.00 0.00 25.00 24.00 -1.00 
2 24.00 22.00 -2.00 19.00 16.00 -3.00 
3 51.00 49.00 -2.00 19.00 17.00 -2.00 
4 31.00 34.00 +3.00 22.00 22.00 0.00 
5 45.00 41.00 -4.00 NA NA NA 
6 51.00 49.00 -2.00 36.00 34.00 -2.00 
7 48.00 46.00 -2.00 35.00 32.00 -3.00 
8 NA NA NA NA NA NA 
Table 23: VAFS Weekly Scores (Subject #7); VAFS, Visual Analog Fatigue Scale 
 
 Subject #8 Session One Session Two 
Week VASF pre VASF post VASF change VASF pre VASF post VASF change 
1 41.00 26.00 -15.00 40.00 29.00 -11.00 
2 35.00 24.00 -11.00 NA  NA NA 
3 44.00 30.00 -14.00 44.00 26.00 -18.00 
4 30.00 -19.00 -11.00 40.00 25.00 -15.00 
5 NA NA NA 37.00 31.00 -6.00 
6 48.00 29.00 -19.00 49.00 42.00 -7.00 
7 47.00 32.00 -15.00 62.00 43.00 -19.00 
69 
 
Table 24: VAFS Weekly Scores (Subject #8); VAFS, Visual Analog Fatigue Scale 
Visual Analog Scale of Fatigue Scores (VASF) Averages for Pre & Post Exercise & Change  
 Average Values 
Subjects VASF pre VASF post VASF change 
1 40.1 52.53 +6.47 
2 38.56 40.38 +1.81 
4 32.38 44.25 +11.88 
5 63.73 57.67 -6.00 
6 15.93 43.13 +30.56 
7 33.15 32.00 -1.54 
8 39.77 27.38 -12.38 
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